THURSDAY | AUGUST 27, 2020
|
|
No Data Behind CDC's Testing Guideline Change
— Absent any evidence, experts speculate that supply shortages, politics influenced agency's decision
Previously, the CDC recommended testing for all close contacts of people infected with SARS-CoV-2, even if they didn't have symptoms. Now, close contacts (within 6 feet, more than 15 minutes) "do not necessarily need a test unless you are a vulnerable individual" or if state and local health authorities recommend it.
Although guidance elsewhere on the CDC website calls for close contacts to isolate at home for 14 days after exposure, the new statement on testing merely calls for those individuals to "strictly adhere to CDC mitigation protocols" without further explanation.
The move has left public health experts baffled, as the consensus is that a substantial proportion of transmission is driven by asymptomatic spread.
|
|
Pre-Registrants Receive Live Meeting Credentials Plus Access to Videos for 30-Days After Meeting Ends
Great Reasons to Attend:
- Save time and money: More time in the office with patients and no fear of COVID-19 exposure.
-
Attend the meeting from wherever you want with just about any device.
-
Earn up to 19.75 CMEs.
- For pre-registrants who want to revisit the meeting after the 30-day bonus access ends, we will make the meeting videos and exhibit hall available until next summer for a nominal fee.
- Catch up with your peers from across the country through the many networking tools.
- World-renowned speakers on relevant subjects to IPM, COVID-19 interfacing with IPM, and many other subjects including opioids and regenerative medicine.
- Virtual exhibit hall like nothing you have seen before.
If you have already registered for the Annual Meeting, your registration fee has been transferred to the Virtual Annual Meeting. You will receive your virtual meeting login credentials and CME information tomorrow. Please review the training video that will be in that email to learn more about how to navigate the meeting platform.
|
|
Order Now - Recorded Virtual Review Courses
The following courses are offered:
- Documentation, Coding, Compliance, and Practice Management Review Course
- Controlled Substance Management Review Course
- Pain Medicine and Interventional Pain Management Comprehensive Review Course
|
|
ABIPP Recognizes Your Knowledge and Expertise
The American Board of Interventional Pain Physicians (ABIPP) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
ABIPP now offers the only competency
certification program for regenerative medicine.
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
|
|
TESTS OFFERED
ABIPP Part I - Theoretical written exam - TBD
ABIPP Part II - Oral and Hands-on practical exam - TBD
ABIPP Competency Exam - includes written, oral, and hands-on practical examinations TBD
Combined CSM/CCPM Exam for ABIPP Path – TBD
Competency Exam in Controlled Substance Management – TBD
Competency Exam in Coding, Compliance, and Practice Management - TBD
Regenerative Medicine Competency Exam - includes written, oral, and hands-on practical examinations – TBD
|
|
|
EPA approves a virus-killing coating for American Airlines, studies use by schools
CHICAGO (Reuters) - The U.S. Environmental Protection Agency said on Monday it has granted emergency approval for American Airlines (AAL.O) to use a disinfectant against the coronavirus on certain surfaces that lasts for up to seven days, and is studying whether it could be effective in places like schools.
EPA Administrator Andrew Wheeler said at a news briefing that SurfaceWise2, made by Allied BioScience Inc, is the first long-lasting product approved by the agency to help fight the spread of the novel coronavirus.
American Airlines will begin spraying its airplane cabins with the disinfectant in its home base of Texas after the state filed the request for emergency approval. The carrier hopes to eventually use it across its entire fleet, including its American Eagle regional partners.
The spray does not eliminate the need for cleaning, officials said.
|
|
Pain Physician COVID-19 Special Issue Now Online
Pain Physician, the official journal of ASIPP, has launched a special issue covering COVID-19 issues. The publications range from understanding the pathophysiological mechanisms, epidemiology, implications on interventional pain practices, safety and effectiveness of various modalities of drug therapy, telemedicine, along with the effect on interventional pain management practices, and, finally, the technological impact of COVID-19 on the future of education and health care delivery and multiple guidelines.
Guidelines
Shalini Shah, MD, Sudhir Diwan, MD, Amol Soin, MD, Kartic Rajput, MD, PhD, Amit Mahajan, MBBS, Laxmaiah Manchikanti, MD, Alan D. Kaye, MD, PhD, Joshua A. Hirsch, MD, and Christopher Gharibo, MD
Christopher Gharibo, MD, Amit Sharma, MD, Amol Soin, MD, Shalini Shah, MD, Sudhir Diwan, MD, Ricardo Buenaventura, MD, Devi E. Nampiaparampil, MD, Steve M. Aydin, DO, Sanjay Bakshi, MD, Salahadin Abdi, MD, PhD, Sachin “Sunny” Jha, MD, MS, Harold J. Cordner, MD, Alan D. Kaye, MD, PhD, Alaa Abd-Elsayed, MD, Kenneth D. Candido, MD, Nebojsa Nick Knezevic, MD, PhD, Sairam Atluri, MD, Bradley W. Wargo, DO, Mahendra R. Sanapati, MD, Sukdeb Datta, MD, Joshua A. Hirsch, MD, and Laxmaiah Manchikanti, MD
Systematic Review
Nebojsa Nick Knezevic, MD, PhD, Laxmaiah Manchikanti, MD, Ivan Urits, MD, Vwaire Orhurhu, MD, MPH, Brahma Prasad Vangala, MBBS, Rachana Vanaparthy, MBBS, Mahendra R. Sanapati, MD, Shalini Shah, MD, Amol Soin, MD, Amit Mahajan, MBBS, Sairam Atluri, MD, Alan D. Kaye, MD, PhD, and Joshua A. Hirsch, MD
Survey
Sachin “Sunny” Jha, MD, MS, Shalini Shah, MD, Michael David Calderon, MS, Amol Soin, MD, and Laxmaiah Manchikanti, MD
AND SO MUCH MORE...
|
|
Orphengesic Forte Now Available for Pain Management
Galt Pharmaceuticals announced the launch of Orphengesic® Forte (orphenadrine citrate, aspirin, caffeine tablets) for the symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.
Each Orphengesic Forte tablet contains orphenadrine citrate 50mg, aspirin 770mg, and caffeine 60mg. The orphenadrine component is also indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. While the mechanism of action of orphenadrine citrate in pain management is unclear, it is believed to have analgesic properties in addition to anticholinergic actions.
With regard to safety, adverse reactions associated with treatment may include tachycardia, palpitation, urinary hesitancy or retention, dry mouth, blurred vision, dilation of the pupil, increased intraocular tension, weakness, nausea, vomiting, headache, dizziness, constipation and drowsiness.
|
|
ASIPP® Partners with Fedora Billing And Revenue Cycle Management Company
|
|
ASIPP is now able to offer unique benefits for revenue cycle management with billing, etc.
Fedora is a company known to many of our board members and others. ASIPP® has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis.
Some of the ASIPP® Billing Program highlights are below:
Up to 50% savings for ASIPP® members for their billing or revenue cycle management for their offices and surgery centers:
- Expertise in interventional pain management billing for all types of services
- 99% Clearing House Rate
- 95% First-Time Claim Passage
- 23.4 Average Days in A/R
- Eligibility and Benefits Verification
- Pre-Certification/Prior Authorization
- Denials and A/R Management
|
|
Join The Group Purchasing
Organization Today
|
|
ASIPP® has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.
Click on “view our discounted supplier prices” (Username: ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
|
|
Essentials of Regenerative Medicine in Interventional
Pain Management
|
|
|
|
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.
Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
|
|
| ORDER | Essentials of Regenerative Medicine in IPM
|
|
Control Your Waiting Room TV
Customized waiting room TV exclusively for ASIPP® members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
|
|
|
In addition, PainExam has now collaborated with ASIPP and offer 2 new programs:
|
|
|
|
|
GSIPP 16th Annual Pain Summit
|
|
The Ritz-Carlton Reynolds Plantation
Lake Oconee
|
|
|
|
|
|
|
2020 12th Annual Scientific
Meeting
|
|
|
|
|
|
|
|
|
|